| |
 |
|
Class Information
Number: 424/200.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Recombinant or stably-transformed bacterium encoding one or more heterologous proteins or fragments thereof
Description: Subject matter involving a bacterium into whose genome is integrated one or more nucleic acid sequences encoding one or more heterologous proteins or fragments thereof; or involving a bacterium that carries stable, replicative plasmids that include one or more nucleic acid sequences encoding one or more heterologous proteins or fragments thereof.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6872398 |
Conjugate vaccine against gram-negative bacterial infections |
Mar. 29, 2005 |
| 6866847 |
Method of delivering a protein to poultry |
Mar. 15, 2005 |
| 6863895 |
Mycobacterial sulfation pathway proteins and methods of use thereof |
Mar. 8, 2005 |
| 6861253 |
Polypeptide inducing antibodies neutralizing HIV |
Mar. 1, 2005 |
| 6858213 |
Mycobacterial sulfation pathway proteins and methods of use thereof |
Feb. 22, 2005 |
| 6846488 |
Chimeric antigen-enterotoxin mucosal immunogens |
Jan. 25, 2005 |
| 6835818 |
Mutants of Streptococcal toxin C and methods of use |
Dec. 28, 2004 |
| 6835381 |
Methods for modulating angiogenesis by using the anti-angiogenic angiotensin-7 and polynucleotides encoding therefor |
Dec. 28, 2004 |
| 6811787 |
Over-expressing homologous antigen vaccine and a method of making the same |
Nov. 2, 2004 |
| 6808713 |
Chlamydia antigens and corresponding DNA fragments and uses thereof |
Oct. 26, 2004 |
| 6808711 |
Immunologically active proteins from Borrelia burgdorferi, nucleic acids which encode them, and their use in test kits and as vaccines |
Oct. 26, 2004 |
| 6805868 |
Moraxella catarrhalis antigen, corresponding gene and uses thereof |
Oct. 19, 2004 |
| 6793927 |
Construction of Pasteurella haemolytica vaccines |
Sep. 21, 2004 |
| 6790446 |
Campylobacter vaccine |
Sep. 14, 2004 |
| 6780405 |
Regulated antigen delivery system (RADS) |
Aug. 24, 2004 |
| 6776993 |
Tuberculosis vaccine |
Aug. 17, 2004 |
| 6770275 |
Live attenuated RTX-producing bacteria of the family pasteurellaceae |
Aug. 3, 2004 |
| 6764687 |
Live attenuated bacteria for use in a vaccine |
Jul. 20, 2004 |
| 6764823 |
Antimicrobial methods and materials |
Jul. 20, 2004 |
| 6737521 |
Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria |
May. 18, 2004 |
| 6733760 |
Recombinant toxin A/toxin B vaccine against Clostridium difficile |
May. 11, 2004 |
| 6723323 |
Vibrio Cholerae vaccine candidates and method of their constructing |
Apr. 20, 2004 |
| 6706494 |
BASB028 polypeptides and polynucleotides encoding therefor from moraxella catarrhalis |
Mar. 16, 2004 |
| 6689364 |
Borrelia burgdorferi polypeptides and uses thereof |
Feb. 10, 2004 |
| 6680182 |
Expression of recombinant fusion proteins in attenuated bacteria |
Jan. 20, 2004 |
| 6676949 |
Two-step immunization procedure against Chlamydia infection |
Jan. 13, 2004 |
| 6673353 |
Tuberculosis vaccine |
Jan. 6, 2004 |
| 6660274 |
Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease |
Dec. 9, 2003 |
| 6660261 |
Bordetella strain expressing the FHA hybrid, liposomes and vaccines |
Dec. 9, 2003 |
| 6653461 |
Cytotoxic T lymphocyte epitopes of the major outer membrane protein of Chlamydia trachomatis |
Nov. 25, 2003 |
| 6645505 |
Reporter gene based method for the screening of anti-tuberculosis drugs by using essential and regulatory genes of mycobacteria as drug target |
Nov. 11, 2003 |
| 6613321 |
Live vaccines against gram-negative pathogens, expressing heterologous O-antigens |
Sep. 2, 2003 |
| 6610307 |
Immunity against pasteurella haemolytica leukotoxin |
Aug. 26, 2003 |
| 6607730 |
Chlamydia antigens and corresponding DNA fragments and uses thereof |
Aug. 19, 2003 |
| 6605286 |
Delivery of biologically active polypeptides |
Aug. 12, 2003 |
| 6602506 |
Delivery of proteins into eukaryotic cells with recombinant Yersinia |
Aug. 5, 2003 |
| 6599502 |
Intracellular delivery vehicles |
Jul. 29, 2003 |
| 6585980 |
Flagellin gene, FlaC of Campylobacter |
Jul. 1, 2003 |
| 6585977 |
Non-virulent Porphyromonas gingivalis mutant |
Jul. 1, 2003 |
| 6585976 |
Mycobacterium strain with modified ERP gene and vaccine composition containing same |
Jul. 1, 2003 |
| 6585975 |
Use of Salmonella vectors for vaccination against helicobacter infection |
Jul. 1, 2003 |
| 6565852 |
Methods and compositions for immunotherapy of cancer |
May. 20, 2003 |
| 6562349 |
Otitis media vaccine |
May. 13, 2003 |
| 6562348 |
Recombinant M. tuberculosis auxotrophic for leucine and vaccines using same |
May. 13, 2003 |
| 6558678 |
PREPARATION AND USE OF FORMALIN-KILLED COLONIZATION-FACTOR-ANTIGEN (CFA)-EXPRESSING E. COLI ORGANISMS FOR VACCINATION AGAINST ENTERIC INFECTION/DIARRHEA CAUSED BY ENTEROTOXIGENIC E. COLI BACTE |
May. 6, 2003 |
| 6559295 |
Mycobacterium fol A gene that encodes for the enzyme dihydrofolate reductase |
May. 6, 2003 |
| 6548070 |
Attenuated strains of mycobacteria |
Apr. 15, 2003 |
| 6531313 |
Invasive bacterial vectors for expressing alphavirus replicons |
Mar. 11, 2003 |
| 6503514 |
Attenuated strains of mycobacteria |
Jan. 7, 2003 |
| 6500434 |
Chaperone and adhesin proteins; vaccines, diagnostics and method for treating infections |
Dec. 31, 2002 |
|
|
|
